Locations:
Search IconSearch
June 18, 2019/Neurosciences

Identifying Risks Factors Associated With Extended Length of Stay in Posterior Segmental Instrumented Fusion for Adolescent Idiopathic Scoliosis

Effective pain relief and major postoperative complications correlate with length of stay, study finds

Goodwin, MD

The use of epidural analgesia (EA) may be a protective factor against extended length of stay (LLOS) in patients undergoing posterior segmental instrumented fusion (PSIF) for adolescent idiopathic scoliosis (AIS).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A retrospective cohort study, recently published in the journal Spine Deformity, analyzed a variety of demographic and surgical factors in order to identify independent risk factors associated with increased LOS. The two factors most strongly associated with LLOS were major postoperative complications and the use of EAs for pain management. Other factors with statistically significant correlations were female sex, ≥9 ±2 levels of fusion, amount of operative blood loss, major postoperative complications, lack of EA and higher thoracic kyphosis.

“Length of stay is important in an era of value-based care; however, studies such as this one are concerned with more than reimbursement,” states Ryan Goodwin, MD, Director of Cleveland Clinic’s Center for Pediatric and Adolescent Orthopaedics. “The modifiable risk factors we identified, such as effective pain relief and major postoperative complications, relate to patient safety and well-being and overall quality of care.”

Identifying risks factors associated with extended length of stay

The study involved retrospective analysis of data from pediatric scoliosis patients (n = 407) undergoing surgical correction from January 1, 2009 through December 31, 2017. Researchers defined a short length of stay (SLOS) as fewer than four days, and a LLOS as four or more days.

Of the patients included in this single-institution study, 232 had SLOS, with a mean stay of 3 ±0.5 days. The remaining 175 patients had LLOS, with a mean stay of 6 ±2 days. Researchers looked at factors related to a patient’s demographics, comorbidities and preoperative measurements of scoliosis curve, as well as factors related to the surgery itself and any complications.

Advertisement

Among the demographic characteristics, only female sex had statistically significant associations with LLOS. Higher thoracic kyphosis was the only preoperative radiographic measurement to correlate with LLOS. Comorbidities had no statistically significant impact on LOS.

In terms of surgery-related characteristics and postoperative complications, which might be considered somewhat modifiable risk factors, operative time and the number of osteotomies had no significant impact on LOS. Patients in whom 7 ±2 levels were fused had SLOS compared to patients who had 9 ±2 levels fused.

Opportunity to make meaningful improvements in quality of care

In patients with major postoperative complications, such as the development of motor weakness, the need for transfusion, infection or reoperation, the risk of LLOS increased 11-fold. Patients without EA for pain control, a modifiable factor, had a three-fold increased risk of LLOS. Comorbidities, preoperative curve Cobb angle and number of osteotomies did not have a statistically significant impact on LOS.

Dr. Goodwin notes, “To our knowledge, this is the largest single-institution study, looking at the most comprehensive list of potential risk factors that might impact length of stay in this patient population. One day in a U.S. hospital can cost up to $4,000. Lowering these costs by reducing the number of in-hospital recovery days is good for everyone involved—patients, providers and payers.”

Advertisement

Related Articles

Woman sitting in a chair and receiving a drug infusion
November 4, 2025/Neurosciences
Low-Dose Ketamine Protocol for Chronic Refractory Pain

Cleveland Clinic study investigated standard regimen

portrait of Dr. Hamid Borghei-Razavi against a decorative background
November 3, 2025/Neurosciences/Podcast
Innovations in Trigeminal Neuralgia Management (Podcast)

Despite the condition’s debilitating, electric shock-like pain, treatment options are better than ever

side-by-side scans of a vein in the brain
October 28, 2025/Neurosciences/Case Study
Case Study: Pulsatile Tinnitus From Emissary Veins Treated With Transvenous Embolization

Innovative approach to the procedure can yield significant relief in complex cases

Man on an exercise bike with another man assisting
October 22, 2025/Neurosciences/Research
DBS Trial Expected to Yield Novel Insights into Exercise and Parkinson’s

Cleveland Clinic researchers awarded $3.2 million for first-of-its-kind investigation

Portrait of Dr. Margolius
October 16, 2025/Neurosciences/Podcast
Genetics: The Cause and a Cause for Hope in Huntington’s Disease (Podcast)

Gene-based treatments could be the future for neurodegenerative condition

older man at a table with younger man handing him pill containers
October 15, 2025/Neurosciences/Brain Health
Real-World Data Suggest Two Antidiabetic Drug Classes May Curb Alzheimer’s Risk

Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors

Two people working in a community garden
Rehabilitation: Beyond Recovery, Toward Renewed Participation

Tasked-based therapy improves social connection and quality of life

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

Ad